For instance, the abundance of CD4+ T cells is higher in patients with soft tissue sarcoma (STS) (149), ccRCC (110) and HCC (148) but the opposite is found in glioma patients (156). This evidence concerns the gene CD4 and hepatocellular carcinoma.